FGEN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Fibrogen Inc (FGEN).


$53.36M Market Cap.

As of 03/17/2025 5:00 PM ET (MRY) • Disclaimer

FGEN Market Cap. (MRY)


FGEN Shares Outstanding (MRY)


FGEN Assets (MRY)


Total Assets

$214.53M

Total Liabilities

$398.16M

Total Investments

$0

FGEN Income (MRY)


Revenue

$29.62M

Net Income

-$47.58M

Operating Expense

$164.48M

FGEN Cash Flow (MRY)


CF Operations

-$138.00M

CF Investing

$125.99M

CF Financing

-$255.00K

FGEN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

FGEN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$214,525,000 (-49.35%)

$423,529,000 (-30.58%)

$610,087,000 (-21.16%)

$773,821,000 (-6.41%)

Assets Current

$196,509,000 (-40.73%)

$331,559,000 (-32.72%)

$492,826,000 (3.96%)

$474,059,000 (-37.22%)

Assets Non-Current

$18,016,000 (-80.41%)

$91,970,000 (-21.57%)

$117,261,000 (-60.88%)

$299,762,000 (317.90%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$225,602,000 (-10.50%)

-$204,166,000 (-851.96%)

-$21,447,000 (-110.25%)

$209,146,000 (-50.46%)

Property Plant & Equipment Net

$0 (0%)

$81,219,000 (-19.18%)

$100,498,000 (-15.82%)

$119,389,000 (82.84%)

Cash & Equivalents

$50,482,000 (-55.60%)

$113,688,000 (-26.98%)

$155,700,000 (-9.07%)

$171,223,000 (-74.76%)

Accumulated Other Comprehensive Income

-$5,732,000 (16.63%)

-$6,875,000 (-20.19%)

-$5,720,000 (-37.40%)

-$4,163,000 (7.47%)

Deferred Revenue

$141,998,000 (-16.62%)

$170,295,000 (-14.19%)

$198,461,000 (-2.07%)

$202,658,000 (39.74%)

Total Investments

$0 (0%)

$128,846,000 (-53.62%)

$277,789,000 (-31.86%)

$407,660,000 (2991.14%)

Investments Current

$0 (0%)

$121,898,000 (-54.23%)

$266,308,000 (13.82%)

$233,967,000 (2772.88%)

Investments Non-Current

$0 (0%)

$6,948,000 (-39.48%)

$11,481,000 (-93.39%)

$173,693,000 (3343.56%)

Inventory

$3,155,000 (-92.41%)

$41,565,000 (2.79%)

$40,436,000 (30.38%)

$31,015,000 (87.63%)

Trade & Non-Trade Receivables

$481,000 (-96.17%)

$12,553,000 (-22.98%)

$16,299,000 (-6.33%)

$17,401,000 (-58.45%)

Trade & Non-Trade Payables

$5,064,000 (-71.80%)

$17,960,000 (-41.61%)

$30,758,000 (17.86%)

$26,097,000 (5.28%)

Accumulated Retained Earnings (Deficit)

-$1,889,499,000 (-2.58%)

-$1,841,920,000 (-18.25%)

-$1,557,688,000 (-23.23%)

-$1,264,034,000 (-29.78%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$131,956,000 (-35.30%)

$203,961,000 (46.50%)

$139,218,000 (39.61%)

$99,720,000 (150.79%)

Debt Current

$0 (0%)

$14,077,000 (36.78%)

$10,292,000 (-5.96%)

$10,944,000 (-19.04%)

Debt Non-Current

$131,956,000 (-30.51%)

$189,884,000 (47.28%)

$128,926,000 (45.23%)

$88,776,000 (238.27%)

Total Liabilities

$398,160,000 (-32.02%)

$585,728,000 (-4.23%)

$611,567,000 (12.27%)

$544,708,000 (41.34%)

Liabilities Current

$133,306,000 (-38.76%)

$217,668,000 (-20.43%)

$273,562,000 (21.32%)

$225,497,000 (38.18%)

Liabilities Non-Current

$264,854,000 (-28.04%)

$368,060,000 (8.89%)

$338,005,000 (5.89%)

$319,211,000 (43.66%)

FGEN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$29,621,000 (-79.95%)

$147,752,000 (4.99%)

$140,734,000 (-40.19%)

$235,309,000 (33.46%)

Cost of Revenue

$15,561,000 (-17.44%)

$18,848,000 (-7.06%)

$20,280,000 (57.56%)

$12,871,000 (45.12%)

Selling General & Administrative Expense

$49,330,000 (-57.20%)

$115,252,000 (-7.57%)

$124,688,000 (0.62%)

$123,925,000 (16.46%)

Research & Development Expense

$95,692,000 (-66.17%)

$282,861,000 (-4.69%)

$296,791,000 (-23.32%)

$387,043,000 (53.03%)

Operating Expenses

$164,476,000 (-59.95%)

$410,719,000 (-2.55%)

$421,479,000 (-17.51%)

$510,968,000 (42.20%)

Interest Expense

$8,247,000 (-46.90%)

$15,532,000 (978.61%)

$1,440,000 (33.95%)

$1,075,000 (-55.25%)

Income Tax Expense

-$269,000 (-9066.67%)

$3,000 (-99.16%)

$358,000 (3.17%)

$347,000 (-3.61%)

Net Loss Income from Discontinued Operations

-$105,519,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$47,579,000 (83.26%)

-$284,232,000 (3.21%)

-$293,654,000 (-1.25%)

-$290,023,000 (-53.22%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$47,579,000 (83.26%)

-$284,232,000 (3.21%)

-$293,654,000 (-1.25%)

-$290,023,000 (-53.22%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$47,579,000 (83.26%)

-$284,232,000 (3.21%)

-$293,654,000 (-1.25%)

-$290,023,000 (-53.22%)

Weighted Average Shares

$100,044,000 (2.82%)

$97,303,000 (3.98%)

$93,582,000 (1.34%)

$92,349,000 (2.78%)

Weighted Average Shares Diluted

$100,044,000 (2.82%)

$97,303,000 (3.98%)

$93,582,000 (1.34%)

$92,349,000 (2.78%)

Earning Before Interest & Taxes (EBIT)

-$39,601,000 (85.26%)

-$268,697,000 (7.94%)

-$291,856,000 (-1.13%)

-$288,601,000 (-54.72%)

Gross Profit

$14,060,000 (-89.09%)

$128,904,000 (7.02%)

$120,454,000 (-45.85%)

$222,438,000 (32.84%)

Operating Income

-$150,416,000 (46.63%)

-$281,815,000 (6.38%)

-$301,025,000 (-4.33%)

-$288,530,000 (-50.37%)

FGEN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$125,993,000 (-18.00%)

$153,657,000 (72.42%)

$89,116,000 (120.87%)

-$426,972,000 (-194.36%)

Net Cash Flow from Financing

-$255,000 (-100.21%)

$122,749,000 (162.42%)

$46,776,000 (8408.35%)

-$563,000 (-104.22%)

Net Cash Flow from Operations

-$137,999,000 (56.19%)

-$315,021,000 (-115.87%)

-$145,933,000 (-77.46%)

-$82,232,000 (-200.77%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$11,510,000 (72.60%)

-$42,012,000 (-170.64%)

-$15,523,000 (96.94%)

-$507,170,000 (-191.86%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$656,000 (101.87%)

-$35,000,000 (-40.00%)

-$25,000,000 (-782.46%)

Net Cash Flow - Investment Acquisitions and Disposals

$125,213,000 (-19.49%)

$155,520,000 (21.64%)

$127,851,000 (132.22%)

-$396,786,000 (-186.39%)

Capital Expenditure

$780,000 (130.96%)

-$2,519,000 (32.56%)

-$3,735,000 (27.98%)

-$5,186,000 (-29.84%)

Issuance (Repayment) of Debt Securities

-$40,000 (-100.06%)

$70,848,000 (48.34%)

$47,759,000 (910.57%)

-$5,892,000 (54.76%)

Issuance (Purchase) of Equity Shares

$139,000 (-99.73%)

$52,138,000 (1146.13%)

$4,184,000 (-67.06%)

$12,701,000 (-66.43%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$751,000 (122.11%)

-$3,397,000 (38.03%)

-$5,482,000 (-311.09%)

$2,597,000 (-44.69%)

Share Based Compensation

$25,215,000 (-50.33%)

$50,767,000 (-22.61%)

$65,601,000 (-7.81%)

$71,161,000 (-2.14%)

Depreciation Amortization & Accretion

$2,692,000 (-72.89%)

$9,930,000 (-6.36%)

$10,604,000 (-28.39%)

$14,809,000 (-32.83%)

FGEN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

47.50% (-45.53%)

87.20% (1.87%)

85.60% (-9.42%)

94.50% (-0.53%)

Profit Margin

-160.60% (16.53%)

-192.40% (7.81%)

-208.70% (-69.26%)

-123.30% (-14.80%)

EBITDA Margin

-124.60% (28.84%)

-175.10% (12.36%)

-199.80% (-71.65%)

-116.40% (-24.76%)

Return on Average Equity (ROAE)

20.50% (-90.40%)

213.50% (148.48%)

-440.40% (-343.06%)

-99.40% (-126.94%)

Return on Average Assets (ROAA)

-16.70% (71.55%)

-58.70% (-32.51%)

-44.30% (-23.06%)

-36.00% (-55.84%)

Return on Sales (ROS)

-133.70% (26.50%)

-181.90% (12.30%)

-207.40% (-69.17%)

-122.60% (-15.88%)

Return on Invested Capital (ROIC)

-22.40% (74.31%)

-87.20% (-3.69%)

-84.10% (-8.94%)

-77.20% (-30.19%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.1 (-262.83%)

-0.3 (94.04%)

-5.1 (-13.63%)

-4.49 (74.46%)

Price to Sales Ratio (P/S)

1.79 (206.16%)

0.58 (-94.52%)

10.65 (92.50%)

5.53 (-70.72%)

Price to Book Ratio (P/B)

-0.24 (44.50%)

-0.43 (99.39%)

-70.18 (-1222.91%)

6.25 (-21.84%)

Debt to Equity Ratio (D/E)

-1.76 (38.48%)

-2.87 (89.94%)

-28.52 (-1195.05%)

2.6 (185.21%)

Earnings Per Share (EPS)

-0.48 (83.56%)

-2.92 (7.01%)

-3.14 (0.00%)

-3.14 (-48.82%)

Sales Per Share (SPS)

0.3 (-80.50%)

1.52 (0.93%)

1.5 (-40.97%)

2.55 (29.87%)

Free Cash Flow Per Share (FCFPS)

-1.37 (57.95%)

-3.26 (-104.07%)

-1.6 (-68.85%)

-0.95 (-209.61%)

Book Value Per Share (BVPS)

-2.25 (-7.48%)

-2.1 (-816.16%)

-0.23 (-110.11%)

2.27 (-51.79%)

Tangible Assets Book Value Per Share (TABVPS)

2.14 (-50.75%)

4.35 (-33.23%)

6.52 (-22.20%)

8.38 (-8.94%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (80.00%)

-5 (-25.00%)

-4 (73.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.46 (-124.04%)

-0.65 (87.26%)

-5.13 (-23.64%)

-4.15 (76.36%)

Asset Turnover

0.1 (-65.90%)

0.3 (43.87%)

0.21 (-27.40%)

0.29 (35.19%)

Current Ratio

1.47 (-3.22%)

1.52 (-15.48%)

1.8 (-14.27%)

2.1 (-54.57%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$137,219,000 (56.79%)

-$317,540,000 (-112.16%)

-$149,668,000 (-71.21%)

-$87,418,000 (-212.64%)

Enterprise Value (EV)

$53,983,796 (-68.05%)

$168,938,936 (-88.28%)

$1,441,837,162 (27.03%)

$1,135,012,196 (-60.66%)

Earnings Before Tax (EBT)

-$47,848,000 (83.17%)

-$284,229,000 (3.09%)

-$293,296,000 (-1.25%)

-$289,676,000 (-53.32%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$36,909,000 (85.74%)

-$258,767,000 (7.99%)

-$281,252,000 (-2.72%)

-$273,792,000 (-66.46%)

Invested Capital

$162,693,000 (-45.06%)

$296,134,000 (-7.47%)

$320,043,000 (-32.88%)

$476,821,000 (1805.61%)

Working Capital

$63,203,000 (-44.51%)

$113,891,000 (-48.06%)

$219,264,000 (-11.79%)

$248,562,000 (-58.01%)

Tangible Asset Value

$214,525,000 (-49.35%)

$423,529,000 (-30.58%)

$610,087,000 (-21.16%)

$773,821,000 (-6.41%)

Market Capitalization

$53,357,796 (-38.78%)

$87,158,936 (-94.21%)

$1,505,202,162 (15.15%)

$1,307,210,196 (-61.27%)

Average Equity

-$232,432,750 (-74.62%)

-$133,107,000 (-299.65%)

$66,671,750 (-77.14%)

$291,630,000 (-32.50%)

Average Assets

$284,504,250 (-41.27%)

$484,406,500 (-26.93%)

$662,911,750 (-17.66%)

$805,063,250 (-1.55%)

Invested Capital Average

$176,899,750 (-42.59%)

$308,114,000 (-11.20%)

$346,966,500 (-7.15%)

$373,668,750 (18.79%)

Shares

100,770,153 (2.47%)

98,340,219 (4.66%)

93,957,688 (1.35%)

92,709,943 (1.87%)